Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics
Ashitaba seems to improve glucose intolerance and decrease triglyceride (TG) and total cholesterol (TC), which contribute to the development of non-alcoholic fatty liver disease (NAFLD). However, it remains to be explored the mechanism of Ashitaba in managing NAFLD. We determined the impact of Ashit...
Main Authors: | Huan Yang, Yunshan Li, Weihong Xu, Wenjuan Liu, Ying Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1247851/full |
Similar Items
-
Safety of ashitaba sap as a Novel food pursuant to Regulation (EU) 2015/2283
by: EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al.
Published: (2024-03-01) -
Efficacy of Transdermal Delivery Nano Ethosomal Gel from Ashitaba Leaves on In-vivo Burn Wound Healing in Albino Rats
by: Akhmad Afifudin Al-Anshori, et al.
Published: (2023-10-01) -
Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice
by: Minghua Yang, et al.
Published: (2023-07-01) -
Pemanfaatan Seduhan Daun Ashitaba dengan Simvastatin dalam Menurunkan Kadar LDL Tikus Putih Jantan Strain Wistar
by: Ernawati Ernawati, et al.
Published: (2018-09-01) -
Hepatoprotective effect of Typhaneoside on non-alcoholic fatty liver disease via farnesoid X receptor in vivo and in vitro
by: Yi Zheng, et al.
Published: (2023-08-01)